Taisho Pharmaceutical Holdings

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

VIE STYLE offers wearable music device and AI technology services.

AuB, Inc., founded in 2015 and based in Chuo, Japan, focuses on researching and developing supplements, foods, and beverages aimed at enhancing the intestinal environment of athletes. The company specializes in intestinal microflora analysis, which is integral to improving athletic performance and maintaining overall human health. AuB offers a range of health supplements and cosmetics that are informed by microbiome research and stool sample analysis of athletes. Additionally, the company provides dietary improvement services tailored to the results of an athlete's intestinal flora data, enabling both consumers and athletes to optimize their health and performance.

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

Moodify develops an AI-powered platform for designing fragrances. Harnessing advanced machine learning techniques and neuroscience research, Moodify enables brands to create scalable, compliant, and sustainable fragrance formulas efficiently.

aiwell Inc. is a Tokyo-based company focused on the research and development of AI proteomics, which involves the analysis of protein changes in living organisms to detect signs of health conditions. The company's platform digitizes proteins from humans and livestock, facilitating sample processing, small-volume analysis, and comparative imaging. aiwell offers innovative solutions, including aiwell care, a micro blood sampling kit that enables users to conduct blood tests at home. Furthermore, it provides AI-driven support for diagnosis, drug discovery, and remote medical care. The company collaborates with the Tokyo Institute of Technology to advance its research initiatives. aiwell Inc. was established in 2018 and was formerly known as CF Partners Co., Ltd.

Nanotis Corporation, founded in 2016 and based in Tokyo, Japan, specializes in the development of instant diagnostic devices aimed at addressing challenges in infectious disease testing, particularly for influenza. The company manufactures microchip-based devices that allow users to quickly and accurately diagnose illnesses. By providing early diagnosis solutions, Nanotis supports medical professionals in practical healthcare settings, thereby enhancing the efficiency of healthcare delivery and improving patient outcomes.

Quantum Operation, Inc. is a Tokyo-based company founded in 2017 that specializes in the development of innovative IoT wearable devices, particularly for blood sugar level management. The company focuses on creating smart watches designed to enhance diabetes management by minimizing the need for painful needle sticks. In addition to its healthcare technology, Quantum Operation also develops speech recognition systems, digital signage solutions, and AI surveillance cameras. Furthermore, the company provides IoT consulting services and engages in YouTuber movie production, showcasing its diverse capabilities within the technology sector.

UPSA SAS is a company focused on addressing pain and self-medication through its range of products. It manufactures over-the-counter medicines aimed at various health issues, including flu, vitality, digestion, and sleep quality. The company offers pharmaceuticals, food supplements, and medical devices designed for patients of all ages, from infants to seniors. By providing these products, UPSA SAS aims to support both consumers and pharmacists in managing everyday health challenges.